Impact of HIV subtype on performance of the limiting antigen-Avidity enzyme immunoassay, the bio-rad avidity assay, and the BED capture immunoassay in Rakai, Uganda

AIDS Research and Human Retroviruses

Volumn 30, Issue 4, 2014, Pages 339-344

  Longosz, Andrew F ^a   Serwadda, David ^b,c   Nalugoda, Fred ^b   Kigozi, Godfrey ^b   Franco, Veronica ^d   Gray, Ronald H ^b,d   Quinn, Thomas C ^a,d   Eshleman, Susan H ^d   Laeyendecker, Oliver ^a,d  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b RAKAI HEALTH SCIENCES PROGRAM   (Uganda)

^c MAKERERE UNIVERSITY SCHOOL OF PUBLIC HEALTH   (Uganda)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN;

ARTICLE; BED CAPTURE IMMUNOASSAY; BIO RAD AVIDITY ASSAY; CLINICAL ARTICLE; ENZYME IMMUNOASSAY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN TISSUE; IMMUNOASSAY; INTERMETHOD COMPARISON; LABORATORY TEST; MALE; PERFORMANCE; PRIORITY JOURNAL; UGANDA; VIRUS CLASSIFICATION; VIRUS TYPING;

ADOLESCENT; ADULT; ANTIBODY AFFINITY; COHORT STUDIES; EPIDEMIOLOGICAL MONITORING; FEMALE; GENOTYPE; HIV; HIV ANTIBODIES; HIV ANTIGENS; HIV INFECTIONS; HUMANS; IMMUNOASSAY; MALE; MASS SCREENING; MIDDLE AGED; UGANDA; YOUNG ADULT;

EID: 84898734945     PISSN: 08892229     EISSN: 19318405     Source Type: Journal    
DOI: 10.1089/aid.2013.0169     Document Type: Article

References (29)

1. Mastro TD, Kim AA, Hallett T, et al.: Estimating HIV incidence in populations using tests for recent infection: Issues, challenges and the way forward. J HIV AIDS Surveill Epidemiol 2010;2(1):1-14.
2. Busch MP, Pilcher CD, Mastro TD, et al.: Beyond detuning: 10 years of progress and new challenges in the development and application of assays for HIV incidence estimation. AIDS 2010;24(18):2763-2771.
3. Mastro TD: Determining HIV incidence in populations: Moving in the right direction. J Infect Dis 2013;207(2):204-206.
4. Busch MP, Pilcher CD, Mastro TD, et al.: Beyond detuning: 10 years of progress and new challenges in the development and application of assays for HIV incidence estimation. AIDS 2010;24(18):2763-2771.
5. Brookmeyer R, Quinn T, Shepherd M, Mehendale S, Rodrigues J, and Bollinger R: The AIDS epidemic in India: A new method for estimating current human immunodeficiency virus (HIV) incidence rates. Am J Epidemiol 1995; 142(7):709-713. (Pubitemid 26434970)
6. Thomas HI, Wilson S, O'Toole CM, et al.: Differential maturation of avidity of IgG antibodies to gp41, p24 and p17 following infection with HIV-1. Clin Exp Immunol 1996; 103(2):185-191. (Pubitemid 26046589)
7. Dobbs T, Kennedy S, Pau CP, McDougal JS, and Parekh BS: Performance characteristics of the immunoglobulin Gcapture BED-enzyme immunoassay, an assay to detect recent human immunodeficiency virus type 1 seroconversion. J Clin Microbiol 2004;42(6):2623-2628. (Pubitemid 38747513)
8. Hall HI, Song R, Rhodes P, et al.: Estimation of HIV incidence in the United States. JAMA 2008;300(5):520-529.
9. Prejean J, Song R, Hernandez A, et al.: Estimated HIV incidence in the United States, 2006-2009. PLoS One 2011;6(8): e17502.
10. Mermin J, Musinguzi J, Opio A, et al.: Risk factors for recent HIV infection in Uganda. JAMA 2008;300(5):540-549.
11. Masciotra S, Dobbs T, Candal D, et al.: Antibody Avidity-Based Assay for Identifying Recent HIV-1 Infections Based on Genetic Systems TM 1/2 plus O EIA. 17th Conference on Retroviruses and Opportunistic Infections, San Francisco, CA, February 16-19, 2010. Abstract 937.
12. Laeyendecker O, Brookmeyer R, Cousins MM, et al.: HIV incidence determination in the United States: A multiassay approach. J Infect Dis 2013;207(2):232-239.
13. Brookmeyer R, Konikoff J, Laeyendecker O, and Eshleman SH: Estimation of HIV incidence using multiple biomarkers. Am J Epidemiol 2013;177(3):264-272.
14. Brookmeyer R, Laeyendecker O, Donnell D, and Eshleman S: Cross-sectional HIV incidence estimation in HIV prevention research. J Acquir Immune Defic Syndr 2013;63(Suppl 2): S233-239.
15. Peeters M, Toure-Kane C, and Nkengasong JN: Genetic diversity of HIV in Africa: Impact on diagnosis, treatment, vaccine development and trials. AIDS 2003;17(18):2547-2560. (Pubitemid 38402333)
16. Robertson DL, Anderson JP, Bradac JA, et al.: HIV-1 nomenclature proposal. Science 2000;288(5463):55-56.
17. Lihana RW, Ssemwanga D, Abimiku A, and Ndembi N: Update on HIV-1 diversity in Africa: A decade in review. AIDS Rev 2012;14(2):83-100.
18. Hemelaar J, Gouws E, Ghys PD, and Osmanov S: Global trends in molecular epidemiology of HIV-1 during 2000-2007. AIDS 2011;25(5):679-689.
19. Hierholzer M, Graham RR, El Khidir I, et al.: HIV type 1 strains from East and West Africa are intermixed in Sudan. AIDS Res Hum Retroviruses 2002;18(15):1163-1166. (Pubitemid 35191779)
20. Young CL, Hu DJ, Byers R, et al.: Evaluation of a sensitive/less sensitive testing algorithm using the bioMerieux Vironostika-LS assay for detecting recent HIV-1 subtype B' or E infection in Thailand. AIDS Res Hum Retroviruses 2003;19(6): 481-486. (Pubitemid 36793768)
21. Parekh BS, Hanson DL, Hargrove J, et al.: Determination of mean recency period for estimation of HIV Type 1 incidence with the BED-capture EIA in persons infected with diverse subtypes. AIDS Res Hum Retroviruses 2011;27:265-273.
22. Parekh BS, Hu DJ, Vanichseni S, et al.: Evaluation of a sensitive/less-sensitive testing algorithm using the 3A11-LS assay for detecting recent HIV seroconversion among individuals with HIV-1 subtype B or E infection in Thailand. AIDS Res Hum Retroviruses 2001;17(5):453-458. (Pubitemid 32506937)
23. Laeyendecker O, Brookmeyer R, Mullis C, et al.: Specificity of four laboratory approaches for cross-sectional HIV incidence determination: Analysis of samples from adults with known non-recent HIV infection from five African countries. AIDS Res Hum Retroviruses 2012;28(10):1177-1183.
24. Mullis CE, Munshaw S, Grabowski MK, et al.: Differential Misclassification of HIV-1 Cross-Sectional Incidence Assays by Subtype in Rakai, Uganda. 19th Conference on Retroviruses and Opportunistic Infections, Seattle, Washington, 2012. Abstract 541.
25. Duong YT, Qiu M, De AK, et al.: Detection of recent HIV-1 infection using a new limiting-Antigen avidity assay: Potential for HIV-1 incidence estimates and avidity maturation studies. PLoS One 2012;7(3):e33328.
26. Grabowski M, Redd A, Mueller A, et al.: The Natural Selection of HIV Subtypes Due to Differential Infectivity and Pathogenicity Is Accelerated by ART: Rakai, Uganda. 19th Conference on Retroviruses and Opportunistic Infections, Seattle, WA, 2012. Abstract 521.
27. Collinson-Streng AN, Redd AD, Sewankambo NK, et al.: Geographic HIV type 1 subtype distribution in Rakai district, Uganda. AIDS Res Hum Retroviruses 2009;25(10): 1045-1048.
28. Wendel SK, Mullis CE, Eshleman SH, et al.: Effect of natural and ARV-induced viral suppression and viral breakthrough on anti-HIV antibody proportion and avidity in patients with HIV-1 subtype B infection. PLoS One 2013;8(2): e55525.
29. Longosz AF, et al.: Characterization of Immune Responses in Ugandan Women Infected with Subtype A and D HIV Using the BED Capture Immunoassay and an Antibody Avidity Assay. 20th Conference on Retroviruses and Opportunistic Infections, Atlanta, Georgia, 2013. Abstract 1057.